Compared to heart failure patients with severe secondary mitral regurgitation who were treated with guideline-directed medical therapy alone, those randomized to a MitraClip procedure plus optimal medical therapy demonstrated relative reductions of 47 percent for heart failure hospitalizations and 38 percent for mortality at two years of follow-up.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear Cardiology (ASNC) submitted a letter to BlueCross BlueShield (BCBS) of Tennessee urging an expansion of cardiac PET coverage.

Performing coronary CT angiography (CCTA) in addition to standard care is associated with a lower risk of death from coronary artery disease than standard care alone, according to research published in the New England Journal of Medicine.

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.

DUBLIN and MUNICH — August 28, 2018 — Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures.

Vienna, VA (August 13, 2018) — B. Kelly Han, MD, is the recipient of the inaugural 2018 DeHaan Award for Innovation in Cardiology, which includes a $200,000 grant.

Jonathan R. Lindner, MD, was elected president of the American Society of Echocardiography (ASE) at the ASE’s 29th Annual Scientific Sessions in Nashville, Tennessee.

The 17,000-member American Society of Echocardiography (ASE) named Jonathan R. Lindner, MD, president of the organization during its 29th annual scientific sessions in Nashville, Tennessee.